Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 67Colorectal Neoplasms 36Central Nervous System Neoplasms 36Colonic Neoplasms 34Rectal Neoplasms 32Glioblastoma 23Gliosarcoma 20Carcinoma, Non-Small-Cell Lung 20Lung Neoplasms 18Stomach Neoplasms 16Pancreatic Neoplasms 15Sarcoma 14Ovarian Neoplasms 13Head and Neck Neoplasms 13Prostatic Neoplasms 12Squamous Cell Carcinoma of Head and Neck 11Neoplasm Metastasis 11Melanoma 11Astrocytoma 11Esophageal Neoplasms 10Carcinoma, Ovarian Epithelial 10Brain Neoplasms 10Uterine Cervical Neoplasms 9Kidney Neoplasms 9Fallopian Tube Neoplasms 9Carcinoma, Intraductal, Noninfiltrating 9Breast Carcinoma In Situ 9Breast Neoplasms, Male 8Adenocarcinoma Of Esophagus 8Liver Neoplasms 7

Interventions

Chemotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Stereotactic Body Radiation Therapy × Chemotherapy, Adjuvant × Clear all
NCT05411809 2022-06-09

The ctDNA for Evaluating Whether to Use Adjuvant Therapy After SBRT in Patients With Early Lung Cancer

Peking University Third Hospital

Phase NA Not yet recruiting
180 enrolled

Stereotactic Body Radiation Therapy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡